|

Diabetes Clinical Trials in Connecticut

54 recruiting studies across 16 cities

All Trials in Connecticut

Phase
Trial Phase Location
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Bloomfield
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes MellitusPhase 3Bridgeport
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesPhase 3Bridgeport
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinPhase 3Bridgeport
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusPhase 3Bridgeport
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes MellitusPhase 3Bridgeport
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePhase 3Bridgeport
A Novel Digital Tool Clinicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk FactorsN/AFarmington
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 2Hartford
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)Phase 3Manchester
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 DiabetesPhase 3New Haven
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMPhase 3New Haven
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus—New Haven
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 DiabetesPhase 1/2New Haven
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 DiabetesPhase 3New Haven
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)Phase 3New Haven
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 ObesityPhase 3New Haven
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 DiabetesPhase 2New Haven
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesPhase 3New Haven
Building and Sustaining Exercise Habits for Adults With Type 1 DiabetesN/ANew Haven
Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM AccessN/ANew Haven
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational DiabetesPhase 4New Haven
Digital Mindfulness for Young Adults With Type 1 DiabetesN/ANew Haven
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial DiseasePhase 2New Haven
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 SystemN/ANew Haven
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 DiabetesN/ANew Haven
Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) UseN/ANew Haven
Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening—New Haven
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 DiabetesPhase 2New Haven
Kidney Precision Medicine Project—New Haven
Mechanisms of Ultrasound Neuromodulation Effects in DiabetesN/ANew Haven
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity TreatmentPhase 2New Haven
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATGPhase 2New Haven
Registry for Stage 2 Type 1 Diabetes—New Haven
Regulation of Brain Glucose Metabolism in Type 1 DiabetesEarly 1New Haven
Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)N/ANew Haven
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes MellitusPhase 2New Haven
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney DiseasePhase 2New Haven
T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 DiabetesN/ANew Haven
Transformative Research in Diabetic Nephropathy—New Haven
TrialNet Pathway to Prevention of T1D—New Haven
Type 1 Diabetes Extension Study—New Haven
Ultrasound Effects on Glycemic Control in T2DMN/ANew Haven
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 DiabetesPhase 3Stamford
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or OverweightPhase 2Stamford
Diabetes Learning in Virtual Environments Just in Time for Community ReentryN/AStorrs
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)Phase 3Waterbury
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 DiabetesPhase 3Waterbury
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to CagrisemaPhase 3Waterbury
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without DiabetesPhase 2Waterbury
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)Phase 3Waterford
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic RetinopathyPhase 2Waterford
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 4West Haven
Neurologic Stem Cell Treatment StudyN/AWestport

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.